Our findings suggest that the prevention of the NF-κB and MAPK signaling pathways involving anti-inflammatory activities and regulation of the excitatory/inhibitory balance attributes to the anti-anxiety effects of SP. The gene discussed is NFKB1; the disease is Anxiety.